These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 17199293

  • 1. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD, Fairlie WD, Hadley EB, Lee HS, Umezawa N, Nikolovska-Coleska Z, Wang S, Huang DC, Tomita Y, Gellman SH.
    J Am Chem Soc; 2007 Jan 10; 129(1):139-54. PubMed ID: 17199293
    [Abstract] [Full Text] [Related]

  • 2. Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition.
    Sadowsky JD, Schmitt MA, Lee HS, Umezawa N, Wang S, Tomita Y, Gellman SH.
    J Am Chem Soc; 2005 Aug 31; 127(34):11966-8. PubMed ID: 16117535
    [Abstract] [Full Text] [Related]

  • 3. Exploration of backbone space in foldamers containing alpha- and beta-amino acid residues: developing protease-resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-xL.
    Sadowsky JD, Murray JK, Tomita Y, Gellman SH.
    Chembiochem; 2007 May 25; 8(8):903-16. PubMed ID: 17503422
    [Abstract] [Full Text] [Related]

  • 4. Exploration of structure--activity relationships among foldamer ligands for a specific protein binding site via parallel and split-and-mix library synthesis.
    Murray JK, Sadowsky JD, Scalf M, Smith LM, Tomita Y, Gellman SH.
    J Comb Chem; 2008 May 25; 10(2):204-15. PubMed ID: 18275161
    [Abstract] [Full Text] [Related]

  • 5. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H, Lee GI, Sedey KA, Kutzki O, Park HS, Orner BP, Ernst JT, Wang HG, Sebti SM, Hamilton AD.
    J Am Chem Soc; 2005 Jul 27; 127(29):10191-6. PubMed ID: 16028929
    [Abstract] [Full Text] [Related]

  • 6. The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2.
    Schimmer AD, Hedley DW, Chow S, Pham NA, Chakrabartty A, Bouchard D, Mak TW, Trus MR, Minden MD.
    Cell Death Differ; 2001 Jul 27; 8(7):725-33. PubMed ID: 11464217
    [Abstract] [Full Text] [Related]

  • 7. Paralog-selective ligands for bcl-2 proteins.
    Gemperli AC, Rutledge SE, Maranda A, Schepartz A.
    J Am Chem Soc; 2005 Feb 16; 127(6):1596-7. PubMed ID: 15700967
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
    Day CL, Smits C, Fan FC, Lee EF, Fairlie WD, Hinds MG.
    J Mol Biol; 2008 Jul 25; 380(5):958-71. PubMed ID: 18589438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
    Yin H, Lee GI, Sedey KA, Rodriguez JM, Wang HG, Sebti SM, Hamilton AD.
    J Am Chem Soc; 2005 Apr 20; 127(15):5463-8. PubMed ID: 15826183
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new assay for the discovery of Bcl-XL inhibitors.
    Pisoni C, Cimoli G, Resconi A, Losi D, Lorenzetti R, Parodi S, Carrano L.
    Farmaco; 2005 Apr 20; 60(11-12):938-43. PubMed ID: 16054143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
    Tzung SP, Kim KM, Basañez G, Giedt CD, Simon J, Zimmerberg J, Zhang KY, Hockenbery DM.
    Nat Cell Biol; 2001 Feb 20; 3(2):183-91. PubMed ID: 11175751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.